
Charanjit Aulakh
Examiner (ID: 2304, Phone: (571)272-0678 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625, 1203, 1621 |
| Total Applications | 3771 |
| Issued Applications | 2863 |
| Pending Applications | 382 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16858685
[patent_doc_number] => 20210159430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/907940
[patent_app_country] => US
[patent_app_date] => 2020-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16907940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/907940 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | Jun 21, 2020 | Issued |
Array
(
[id] => 20289400
[patent_doc_number] => 20250314643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => FLUORESCENT COMPLEXES COMPRISING TWO RHODAMINE DERIVATIVES AND A NUCLEIC ACID MOLECULE
[patent_app_type] => utility
[patent_app_number] => 17/617037
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617037 | FLUORESCENT COMPLEXES COMPRISING TWO RHODAMINE DERIVATIVES AND A NUCLEIC ACID MOLECULE | Jun 18, 2020 | Pending |
Array
(
[id] => 16376276
[patent_doc_number] => 20200325118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/904099
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904099 | Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor | Jun 16, 2020 | Issued |
Array
(
[id] => 17727716
[patent_doc_number] => 11384091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
[patent_app_type] => utility
[patent_app_number] => 16/900600
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16722
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900600 | Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | Jun 11, 2020 | Issued |
Array
(
[id] => 16657267
[patent_doc_number] => 20210053903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => APPLYING HANSEN SOLUBILITY PARAMETERS TO METAL-ORGANIC FRAMEWORK SYNTHESIS CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/900109
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900109 | APPLYING HANSEN SOLUBILITY PARAMETERS TO METAL-ORGANIC FRAMEWORK SYNTHESIS CONDITIONS | Jun 11, 2020 | Abandoned |
Array
(
[id] => 16516302
[patent_doc_number] => 20200395560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/899776
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899776 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | Jun 11, 2020 | Issued |
Array
(
[id] => 16673068
[patent_doc_number] => 20210061831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COT MODULATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/898981
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898981 | COT MODULATORS AND METHODS OF USE THEREOF | Jun 10, 2020 | Abandoned |
Array
(
[id] => 18526348
[patent_doc_number] => 11713333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound
[patent_app_type] => utility
[patent_app_number] => 16/892487
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 53357
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1644
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892487 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | Jun 3, 2020 | Issued |
Array
(
[id] => 17884044
[patent_doc_number] => 20220299521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE
[patent_app_type] => utility
[patent_app_number] => 17/596208
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596208 | CHEMOSELECTIVE SENSITIVITY BOOSTER FOR TAGGING A PEPTIDE, PEPTIDE CONJUGATE, OR SIMILAR REACTIVE MOLECULE | Jun 3, 2020 | Pending |
Array
(
[id] => 16516299
[patent_doc_number] => 20200395557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => ORGANIC LIGHT-EMITTING DEVICE AND ORGANOMETALLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/889067
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1409
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/889067 | Organic light-emitting device and organometallic compound | May 31, 2020 | Issued |
Array
(
[id] => 16540948
[patent_doc_number] => 20200407361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => TRICYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/885128
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885128 | Tricyclic compounds | May 26, 2020 | Issued |
Array
(
[id] => 16777965
[patent_doc_number] => 20210115042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => ERGOLINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/883920
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883920 | ERGOLINE COMPOUNDS AND USES THEREOF | May 25, 2020 | Abandoned |
Array
(
[id] => 16466687
[patent_doc_number] => 20200368224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => BUTYRYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF OPIOID USE DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/883291
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883291 | Butyrylcholinesterase inhibitors for treatment of opioid use disorder | May 25, 2020 | Issued |
Array
(
[id] => 20329683
[patent_doc_number] => 12459948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Processes and intermediates for preparing a Btk inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/612034
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3128
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612034 | Processes and intermediates for preparing a Btk inhibitor | May 19, 2020 | Issued |
Array
(
[id] => 16471956
[patent_doc_number] => 20200373494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => LIGHT-EMITTING LAYER-FORMING INK AND MANUFACTURING METHOD OF ORGANIC EL ELEMENT
[patent_app_type] => utility
[patent_app_number] => 16/877509
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877509 | LIGHT-EMITTING LAYER-FORMING INK AND MANUFACTURING METHOD OF ORGANIC EL ELEMENT | May 18, 2020 | Abandoned |
Array
(
[id] => 18706535
[patent_doc_number] => 11793067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Organometallic compound and organic light-emitting device including the same
[patent_app_type] => utility
[patent_app_number] => 15/930248
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22189
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930248 | Organometallic compound and organic light-emitting device including the same | May 11, 2020 | Issued |
Array
(
[id] => 16268779
[patent_doc_number] => 20200270266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => TETRAHYDROISOQUINOLINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/871532
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871532 | Tetrahydroisoquinoline derivatives | May 10, 2020 | Issued |
Array
(
[id] => 16908929
[patent_doc_number] => 11040954
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-22
[patent_title] => CXCR3 receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/872161
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34555
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16872161
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/872161 | CXCR3 receptor agonists | May 10, 2020 | Issued |
Array
(
[id] => 18190893
[patent_doc_number] => 11581498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Organic luminescent material containing 6-silyl-substituted isoquinoline ligand
[patent_app_type] => utility
[patent_app_number] => 16/869770
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11979
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 596
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869770 | Organic luminescent material containing 6-silyl-substituted isoquinoline ligand | May 7, 2020 | Issued |
Array
(
[id] => 17089709
[patent_doc_number] => 11117886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Methods and intermediates for preparing therapeutic compounds
[patent_app_type] => utility
[patent_app_number] => 16/869653
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51460
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869653 | Methods and intermediates for preparing therapeutic compounds | May 7, 2020 | Issued |